An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia. AJP 2023, 17 (2). https://doi.org/10.22377/ajp.v17i2.4859.